ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag disease medicine art quotes science funding

A clinician (off screen) wearing blue gloves presses a diapered infant’s heel against a paper card to collect blood samples.
Did Researchers Really Uncover the Cause of SIDS?
Dan Robitzski | May 18, 2022 | 10 min read
An interesting but preliminary biomarker study’s reception illustrates the challenges of conducting and communicating nuanced research in the era of social media.
Notable Science Quotes
The Scientist | Feb 1, 2017 | 2 min read
Intellectual property theft, gun violence, scientific failure, and more
Speaking of Science
The Scientist | Jan 1, 2012 | 2 min read
January 2012's selection of notable quotes
Opinion: Star Trek Medicine
Dean Tantin | Nov 6, 2014 | 3 min read
An apology for basic research
Speaking of Science
The Scientist | Mar 1, 2016 | 2 min read
March 2016's selection of notable quotes
Zebrafish with fluorescent nervous system in green.
Oust the Mouse: A Plan to Reduce Mammal Use in Drug Development
Natalia Mesa, PhD | Mar 15, 2022 | 7 min read
The Scientist spoke to Mount Desert Island Biological Laboratory’s Jim Strickland about the institute’s new MDI Bioscience initiative to perform more drug testing and development in nonmammalian models.
Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership  to develop first in class therapies in autoimmune disease and immuno-oncology
Pathios Therapeutics | Feb 7, 2019 | 2 min read
Pathios Therapeutics ("Pathios"), an innovative biotech company focused on the development of first in class therapies for autoimmune diseases and immuno-oncology and Sygnature Discovery ("Sygnature"), jointly announce a strategic partnership to accelerate Pathios’ drug discovery and development programmes.
Supplement: Art Caplan
Karen Pallarito | Jan 1, 2008 | 4 min read
Art Caplan By Karen Pallarito A conversation with Penn's renowned ethicist. RELATED ARTICLES Innovative Technology Daniel Skovronsky: Scientist and leader Turning Tobacco into Therapies Biofuel: The Potential Magic Bullet Britton Chance: Still searching for answers Technology Roundup DUSTIN FENSTERMACHER / WONDERFUL MACHINE As a Columbia University philosophy student in the 1970s, Arthur Caplan listened to ongoing discussions about the ethics of
Is Less More?
Mary Beth Aberlin | Jun 1, 2017 | 3 min read
Diets: From art to science
Decisions, Decisions: NIH's Disease-By-Disease Allocations Draw New Fire
Bruce Agnew | Mar 29, 1998 | 8 min read
'BODY-COUNT BUDGETING'? Rep. Ernest Istook (R-Okla.) is concerned that diseases that cost taxpayers the most money may not be getting a proportionate amount of NIH funds. For the third year in a row, the National Institutes of Health came under fire this month for slighting some diseases and favoring more politically correct ills when it parcels out its research-funding billions. "What this whole thing boils down to," NIH director Harold Varmus recently told a special Institute of Medicine (I

Run a Search

ADVERTISEMENT